Dr. Milap Sandhu, Pt, PhD
Claim this profileClinical Trials Milap Sandhu, Pt, PhD is currently running
More about Milap Sandhu, Pt, PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Milap Sandhu, Pt, PhD has experience with
- Acute Intermittent Hypoxia
- Sham-Acute Intermittent Hypoxia
Breakdown of trials Milap Sandhu, Pt, PhD has run
Multiple Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Milap Sandhu, Pt, PhD specialize in?
Milap Sandhu, Pt, PhD focuses on Multiple Sclerosis and Anoxemia. In particular, much of their work with Multiple Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Milap Sandhu, Pt, PhD currently recruiting for clinical trials?
Yes, Milap Sandhu, Pt, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Milap Sandhu, Pt, PhD has studied deeply?
Yes, Milap Sandhu, Pt, PhD has studied treatments such as Acute Intermittent Hypoxia, Sham-Acute Intermittent Hypoxia.
What is the best way to schedule an appointment with Milap Sandhu, Pt, PhD?
Apply for one of the trials that Milap Sandhu, Pt, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.